Retrophin, Inc. Indenture Agreements

4 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Supplemental Indenture for 2.25% Convertible Senior Notes due 2029 between Travere Therapeutics, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
Retrophin, Inc.
Biotechnology
DE
2022
First Supplemental Indenture to 2.50% Convertible Senior Notes due 2025 between Retrophin, Inc. and U.S. Bank National Association
Indenture Agreements
Retrophin, Inc.
Biotechnology
DE
2018
Indenture Agreement between Retrophin, Inc. and U.S. Bank National Association dated September 10, 2018
Indenture Agreements
Retrophin, Inc.
Biotechnology
DE
2018
Indenture Agreement for 4.50% Senior Convertible Notes Due 2019 between Retrophin, Inc. and U.S. Bank National Association
Indenture Agreements
Retrophin, Inc.
Biotechnology
NY
2014